SALIVA AS A DIAGNOSTIC MEDIUM FOR CERTAIN DISEASES
Keywords:
biomarkers, oral diseases, salivary diagnosis, systemic diseasesAbstract
Saliva is a complex biological fluid with a variety of biomolecules, such as DNA, RNA, proteins, metabolites and microbiota, which can be used for the screening and diagnosis of many diseases. In addition, saliva has the characteristics of simple collection, non-invasive and convenient storage, which gives it the potential to replace blood as a new main body of fluid biopsy, and it is an excellent biological diagnostic fluid. In this review, we review research related to saliva diagnostics, including saliva content, techniques and processes related to saliva detection samples, and saliva detection studies in various diseases. The densities of Streptococcus mutans and Lactobacillus in people with high caries activity were much higher than those with low caries. Porphyromonas gingivalis has been confirmed to be closely associated with periodontitis. Currently, an ELISA kit has been developed to specifically detect P. gingivalis in saliva. Compared with qPCR, its detection rate is higher, and the sensitivity and specificity are as high as 92 - 96%, respectively. Therefore, it is expected to become an easy and rapid diagnostic tool for the detection of P. gingivalis and has great potential for rapid screening of periodontitis. Saliva contains various biological components, including DNA, RNA, proteins, microorganisms and metabolites, which are potential biomarkers. Biomarkers can reflect the physiological and pathological state of the body, which is an important basis for personalized medicine. Therefore, comprehensive analysis and identification of various components in human saliva will greatly help us to develop biomarkers related to human health and disease status, early identification of diseases, assessment of prognosis and disease risk, and monitoring the effect of treatment. Currently, more than 100 metabolites have been reported to be altered with the malignant progression of OSCC, such as lactate, choline, glutamate, histidine, sialic acid, and trimethylamine N oxide. Oral microorganisms play an important role in host health and disease. In recent years, some studies have shown that the change of oral microflora will destroy the balance between microorganisms and the human body, together with the influence of risk factors, leading to the occurrence of OSCC. Oral microorganisms, epithelial barrier, immune system, and chronic inflammation constitute the four important factors leading to oral cancer. Therefore, oral microorganisms are potential biomarkers for the early diagnosis of OSCC. The results show that the accuracy of the model is 95.70% and the sensitivity is 100%.This review integrates recent studies and summarizes the research contents of the research progress of saliva in early diagnosis of oral and systemic diseases. This review aims to explore the value and prospect of saliva diagnosis in clinical application.
References
Al-Rawi, N.H., Al-Marzooq, F., Al-Nuaimi, A.S., Hachim, M.Y., & Hamoudi, R. (2020). Salivary microRNA 155, 146a/b and 203: a pilot study for potentially non-invasive diagnostic biomarkers of periodontitis and diabetes mellitus. PLoS One;15: e237004.
Butler-Laporte, G., Lawandi, A., Schiller, I., Yao, M., Dendukuri, N., McDonald, E.G., et al. (2021). Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis. JAMA Intern Med;181:353–60.
Chang, C., Wang, H., Liu, J., Pan, C., Zhang, D., Li, X., et al. (2019). Porphyromonas gingivalis infection promoted the proliferation of oral squamous cell carcinoma cells through the miR-21/ PDCD4/AP-1 negative signaling pathway. ACS Infect Dis;5:1336–47.
Feng, Y., Li, Q., Chen, J., Yi, P., Xu, X., Fan, Y., et al. (2019). Salivary protease spectrum biomarkers of oral cancer. Int J Oral Sci;11:7.
Gonzalez-Moles, M.A., Ruiz-Avila, I., Gonzalez-Ruiz, L, Ayen, A., Gil-Montoya, J.A., & Ramos-Garcia, P. (2019). Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol;96:121–30.
Han, P., Bartold, P.M., Salomon, C., & Ivanovski, S. (2021). Salivary outer membrane vesicles and DNA methylation of small extracellular vesicles as biomarkers for periodontal status: a pilot study. Int J Mol Sci;22:2423.
Jang, X., Chen, X., Chen, Z., Yu, J., Lou, H., & Wu, J. (2021). High-throughput salivary metabolite profiling on an ultralow noise tip-enhanced laser desorption ionization mass spectrometry platform for noninvasive diagnosis of early lung cancer. J Proteome Res;20:4346–56.
Jian, C., Zhao, A., Ma, X., Ge, K., Lu, W., Zhu, W., et al. (2020) Diabetes screening: detection and application of saliva 1, 5 anhydroglucitol by liquid chromatography-mass spectrometry. J Clin Endocrinol Metab;105:114.
Kaczor-Urbanowicz, K.E., Wei, F., Rao, S.L., Kim, J., Shin, H., Cheng, J., et al. (2019). Clinical validity of saliva and novel technology for cancer detection. Biochim Biophys Acta Rev Cancer;1872:49–59.
Lee, J., Baek, S., Koh, J.H., Kim, J.W., Kim, S.Y., et al. (2019). Soluble siglec-5 is a novel salivary biomarker for
primary Sjogren’s syndrome.J Autoimmun;100:114–9.
Lopez-Jornet, P., Aznar, C., Ceron, J., & Asta, T. (2021). Salivary biomarkers in breast cancer: a cross-sectional study. Support Care Cancer;29:889–96.
Mathai, R.A., Vidya, R., Reddy, B.S., Thomas, L., Udupa, K., Kolesar, J., et al. (2019). Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology. J Clin Med;8:373.
Nijakowski, K., & Surdacka, A. (2020). Salivary biomarkers for diagnosis of inflammatory bowel diseases: a systematic review. Int J Oral Sci;21:7477.
Ponti, G., Manfredini, M., & Tomasi, A. (2019). Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology. Crit Rev Oncol Hematol;141:36–42.
Poulet, G., Massias, J., & Taly, V. (2019). Liquid biopsy: general concepts.Acta Cytol;63:449–55.
Romani, C., Salviato, E., Paderno, A., Zanotti, L., Ravaggi, A., Deganello, A., et al. (2021). Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Theranostics;11:2987–99.
Setti, G., Pezzi, M.E., Viani, M.V., Pertinhez, T.A., Cassi, D., Magnoni, C., et al. (2020). Salivary microRNA for diagnosis of cancer and systemic diseases: a systematic review. Int J Mol Sci;21:907.
Shanmugam, A., Hariharan, A.K., Hasina, R., Nair, J.R., Katragadda, S., Irusappan, S., et al. (2021). Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma. Cancer-Am Cancer Soc;127:1576–89.
Sivadasan, P., Gupta, M.K., Sathe, G., Sudheendra, H.V., Sunny, S.P., Renu, D., et al. (2020). Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection. J Proteonomics;212:103574.
Sridharan, G., Ramani, P., Patankar, S., & Vijayaraghavan, R. (2019). Evaluation of salivary metabolomics in oral
leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med;48:299–306.
Wang, Y., Liu, S., Li, B., Jiang, Y., Zhou, X., Chen, J., et al. (2019). Staphylococcus aureus induces COX-2-dependent proliferation and malignant transformation in oral keratinocytes. J Oral Microbiol;11:1643205.
Wood, B.R., Kochan, K., Bedolla, D.E., Salazar-Quiroz, N., Grimley, S.L., Perez-Guaita, D., et al. (2021). Infrared based saliva screening test for COVID-19. Angew Chem Int Ed Engl 2021;60:17102–7.
Xavier, A.D., Acevedo, A.C., Cancado, P.M., Costa, N.A., Pichon, V., Chardin, H., et al. (2020). Using an untargeted metabolomics approach to identify salivary metabolites in women with breast cancer. Metabolites;10:506.
Yang, X.H., Zhang, X.X., Jing, Y., Ding, L., Fu, Y., Wang, S., et al. (2019). Amino acids signatures of distance-related surgical margins of oral squamous cell carcinoma. EBioMedicine;48:81–91.
Ye, Q., Ling, S., Zheng, S., & Xu, X. (2019). Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Mol Cancer;18:114.
Zanoni, D.K., Montero, P.H., Migliacci, J.C., Shah, J.P., Wong, R.J., Ganly, I., et al. (2019). Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol;90:115–21.
Zhang, S., Li, C., Liu, J., Geng, F., Shi, X., Li, Q., et al. (2020). Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. FEBS J;287:4032–47.
Zhang, Y., Huang, S., Jia, S., Sun, Z., Li, S., Li, F., et al. (2021). The predictive power of saliva electrolytes exceeds that of saliva microbiomes in diagnosing early childhood caries. J Oral Microbiol;13:1921486.
Zhou, X., Hao, Y., Peng, X., Li, B., Han, Q., Ren, B., et al. (2021). The Clinical potential of oral microbiota as a screening tool for oral squamous cell carcinomas. Front Cell Infect Microbiol;11:728933.
